Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-123928
Filing Date
2025-12-19
Accepted
2025-12-19 17:00:02
Documents
1
Period of Report
2025-12-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3248
  Complete submission text file 0001213900-25-123928.txt   4848
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Issuer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address
Brady Brian Michael (Reporting) CIK: 0001817386 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39336 | Film No.: 251588347